Inogen | INGN - Ordinary Share Capital


Inogen reported $23K in Ordinary Share Capital for its fiscal quarter ending in December of 2023.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Accuray USD 100K 1000 Sep/2024
AngioDynamics USD 41.57M 127K Sep/2025
Artivion USD 47.84M 468K Dec/2025
AtriCure USD 49.79M 91K Dec/2025
Baxter International USD 516.45M 2.17M Mar/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Boston Scientific USD 1.48B 2.66M Dec/2025
Chart Industries USD 47.87M 72K Mar/2026
Cooper Companies USD 195.11M 14K Mar/2026
Dexcom USD 385.9M 1.1M Mar/2026
Edwards Lifesciences USD 580.7M 0 Dec/2025
Globus Medical USD 135.06M 449K Dec/2025
Inogen USD 23K 0 Dec/2023
Insulet USD 69.26M 1.08M Mar/2026
Medtronic USD 1.28B 1.38M Dec/2025
Orthofix International USD 39.83M 315K Dec/2025
Philips EUR 952.02M 729K Mar/2026
ResMed USD 190.83M 44.86M Mar/2026
Steris USD 98.07M 72K Mar/2026
Stryker USD 382.98M 584K Mar/2026
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Teleflex USD 44.26M 70K Mar/2026
X T L Biopharmaceuticals USD 881.39M 858.25M Jun/2025
Zimmer Biomet Holdings USD 195.5M 2.68M Mar/2026